Search Keyword:


Search option:


IID00976
UniprotQ13557
ProteinCalcium/calmodulin-dependent protein kinase type II subunit delta
GeneCAMK2D
OrganismHomo sapiens
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
Network xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
499
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 3-309 Monomer :
 Evidence X-RAY 6ayw A Reference
       Region 6ayw A 3-7 disorder
       Region 6ayw A 8-300 order
       Region 6ayw A 301-301 disorder
 Evidence X-RAY 6ayw B Reference
       Region 6ayw B 3-6 disorder
       Region 6ayw B 7-299 order
       Region 6ayw B 300-301 disorder
 Evidence X-RAY 5vlo A Reference
       Region 5vlo A 3-7 disorder
       Region 5vlo A 8-21 order
       Region 5vlo A 22-24 disorder
       Region 5vlo A 25-300 order
       Region 5vlo A 301-301 disorder
 Evidence X-RAY 5vlo B Reference
       Region 5vlo B 3-6 disorder
       Region 5vlo B 7-299 order
       Region 5vlo B 300-301 disorder
 Evidence X-RAY 2vn9 A Reference
       Region 2vn9 A 11-309 order
 Evidence X-RAY 2vn9 B Reference
       Region 2vn9 B 11-309 order
Seq 11-335 Hetero dimer : IID00706Complex
 Evidence X-RAY 2wel A Reference
       Region 2wel A 11-276 order
       Region 2wel A 277-280 disorder
       Region 2wel A 281-316 order
       Region 2wel A 317-335 disorder
Seq 294-311 Hetero dimer : P62149
 Evidence X-RAY 3gp2 B Reference
       Region 3gp2 B 294-311 order
Seq 294-315 Hetero dimer : IID00706Complex
 Evidence X-RAY 7zrq B Reference
       Region 7zrq B 294-312 order
       Region 7zrq B 313-315 disorder
Seq 294-315 Hetero tetramer : IID00706Complex
 Evidence X-RAY 7zrp B Reference
       Region 7zrp B 294-315 order
 Evidence X-RAY 7zrp D Reference
       Region 7zrp D 294-315 order
Seq 334-475 Homo tetradecamer :
 Evidence X-RAY 2w2c A Reference
       Region 2w2c A 334-338 disorder
       Region 2w2c A 339-402 order
       Region 2w2c A 403-407 disorder
       Region 2w2c A 408-471 order
       Region 2w2c A 472-475 disorder
 Evidence X-RAY 2w2c B Reference
       Region 2w2c B 334-339 disorder
       Region 2w2c B 340-403 order
       Region 2w2c B 404-407 disorder
       Region 2w2c B 408-471 order
       Region 2w2c B 472-475 disorder
 Evidence X-RAY 2w2c C Reference
       Region 2w2c C 334-340 disorder
       Region 2w2c C 341-402 order
       Region 2w2c C 403-406 disorder
       Region 2w2c C 407-471 order
       Region 2w2c C 472-475 disorder
 Evidence X-RAY 2w2c D Reference
       Region 2w2c D 334-341 disorder
       Region 2w2c D 342-402 order
       Region 2w2c D 403-407 disorder
       Region 2w2c D 408-471 order
       Region 2w2c D 472-475 disorder
 Evidence X-RAY 2w2c E Reference
       Region 2w2c E 334-337 disorder
       Region 2w2c E 338-402 order
       Region 2w2c E 403-407 disorder
       Region 2w2c E 408-471 order
       Region 2w2c E 472-475 disorder
 Evidence X-RAY 2w2c F Reference
       Region 2w2c F 334-340 disorder
       Region 2w2c F 341-402 order
       Region 2w2c F 403-407 disorder
       Region 2w2c F 408-471 order
       Region 2w2c F 472-475 disorder
 Evidence X-RAY 2w2c G Reference
       Region 2w2c G 334-340 disorder
       Region 2w2c G 341-402 order
       Region 2w2c G 403-406 disorder
       Region 2w2c G 407-471 order
       Region 2w2c G 472-475 disorder
 Evidence X-RAY 2w2c H Reference
       Region 2w2c H 334-338 disorder
       Region 2w2c H 339-404 order
       Region 2w2c H 405-406 disorder
       Region 2w2c H 407-471 order
       Region 2w2c H 472-475 disorder
 Evidence X-RAY 2w2c I Reference
       Region 2w2c I 334-337 disorder
       Region 2w2c I 338-402 order
       Region 2w2c I 403-408 disorder
       Region 2w2c I 409-471 order
       Region 2w2c I 472-475 disorder
 Evidence X-RAY 2w2c J Reference
       Region 2w2c J 334-341 disorder
       Region 2w2c J 342-402 order
       Region 2w2c J 403-407 disorder
       Region 2w2c J 408-471 order
       Region 2w2c J 472-475 disorder
 Evidence X-RAY 2w2c K Reference
       Region 2w2c K 334-341 disorder
       Region 2w2c K 342-402 order
       Region 2w2c K 403-405 disorder
       Region 2w2c K 406-471 order
       Region 2w2c K 472-475 disorder
 Evidence X-RAY 2w2c L Reference
       Region 2w2c L 334-339 disorder
       Region 2w2c L 340-404 order
       Region 2w2c L 405-406 disorder
       Region 2w2c L 407-471 order
       Region 2w2c L 472-475 disorder
 Evidence X-RAY 2w2c M Reference
       Region 2w2c M 334-342 disorder
       Region 2w2c M 343-402 order
       Region 2w2c M 403-406 disorder
       Region 2w2c M 407-471 order
       Region 2w2c M 472-475 disorder
 Evidence X-RAY 2w2c N Reference
       Region 2w2c N 334-335 disorder
       Region 2w2c N 336-402 order
       Region 2w2c N 403-407 disorder
       Region 2w2c N 408-471 order
       Region 2w2c N 472-475 disorder
SeqProS predicted 300-309 This region is predicted to be disordered by NeProc and AlphaFold (pLDDT < 68.5). :
       Region 2vn9 A 11-309 order
       Region 2vn9 B 11-309 order
SeqProS predicted 300-316 This region is predicted to be disordered by NeProc and AlphaFold (pLDDT < 68.5). Hetero tetramer : IID00706Complex
       Region 7zrp B 294-315 order
       Region 7zrp D 294-315 order
SeqProS predicted 300-316 This region is predicted to be disordered by NeProc and AlphaFold (pLDDT < 68.5). Hetero dimer : IID00706Complex
       Region 2wel A 281-316 order
SeqProS predicted 300-316 This region is predicted to be disordered by NeProc and AlphaFold (pLDDT < 68.5). Hetero dimer : IID00706Complex
       Region 7zrq B 294-312 order
Seqphosphorylation
    287-287 Phosphothreonine; by autocatalysis
    306-306 Phosphothreonine; by autocatalysis
    307-307 Phosphothreonine; by autocatalysis
    315-315 Phosphoserine
    319-319 Phosphoserine
    330-330 Phosphoserine
    331-331 Phosphothreonine
    333-333 Phosphoserine
    336-336 Phosphothreonine
    337-337 Phosphothreonine
    404-404 Phosphoserine
    490-490 Phosphoserine
    494-494 Phosphoserine
Seqacetylation
    318-318 N6-acetyllysine
    2-2 N-acetylalanine
 
Prediction
NeProc
Disorder 1-5,294-384,472-499
Order 6-293,385-402,408-471
ProS 294-307,313-316,332-370,478-484,494-499
AlphaFold
Disorder 1-7,24-24,300-339,404-407,409-409,472-499
Order 8-23,25-299,340-403,408-408,410-471
Function
Function in SwissProt
Calcium/calmodulin-dependent protein kinase involved in the regulation of Ca(2+) homeostatis and excitation-contraction coupling (ECC) in heart by targeting ion channels, transporters and accessory proteins involved in Ca(2+) influx into the myocyte, Ca(2+) release from the sarcoplasmic reticulum (SR), SR Ca(2+) uptake and Na(+) and K(+) channel transport. Targets also transcription factors and signaling molecules to regulate heart function. In its activated form, is involved in the pathogenesis of dilated cardiomyopathy and heart failure. Contributes to cardiac decompensation and heart failure by regulating SR Ca(2+) release via direct phosphorylation of RYR2 Ca(2+) channel on 'Ser-2808'. In the nucleus, phosphorylates the MEF2 repressor HDAC4, promoting its nuclear export and binding to 14-3-3 protein, and expression of MEF2 and genes involved in the hypertrophic program (PubMed:17179159). Is essential for left ventricular remodeling responses to myocardial infarction. In pathological myocardial remodeling acts downstream of the beta adrenergic receptor signaling cascade to regulate key proteins involved in ECC. Regulates Ca(2+) influx to myocytes by binding and phosphorylating the L-type Ca(2+) channel subunit beta-2 CACNB2. In addition to Ca(2+) channels, can target and regulate the cardiac sarcolemmal Na(+) channel Nav1.5/SCN5A and the K+ channel Kv4.3/KCND3, which contribute to arrhythmogenesis in heart failure. Phosphorylates phospholamban (PLN/PLB), an endogenous inhibitor of SERCA2A/ATP2A2, contributing to the enhancement of SR Ca(2+) uptake that may be important in frequency-dependent acceleration of relaxation (FDAR) and maintenance of contractile function during acidosis (PubMed:16690701). May participate in the modulation of skeletal muscle function in response to exercise, by regulating SR Ca(2+) transport through phosphorylation of PLN/PLB and triadin, a ryanodine receptor-coupling factor. In response to interferon-gamma (IFN-gamma) stimulation, catalyzes phosphorylation of STAT1, stimulating the JAK-STAT signaling pathway (By similarity).
Biological Process
Diagram with PDB data
CAMK2D/CALM12.65 Angstrom crystal structure of Ca/CaM:CaMKIIdelta peptide complex
See also
Diagram with PDB data
HDAC4/YWHAGCrystal structure of 14-3-3 GAMMA